Needham & Company LLC Initiates Coverage on Hinge Health (NYSE:HNGE)

Equities research analysts at Needham & Company LLC initiated coverage on shares of Hinge Health (NYSE:HNGE) in a research report issued to clients and investors on Monday,Benzinga reports. The firm set a “buy” rating and a $47.00 price target on the stock. Needham & Company LLC’s price target suggests a potential upside of 35.21% from the stock’s previous close.

A number of other research firms have also weighed in on HNGE. Barclays initiated coverage on Hinge Health in a research report on Monday. They issued an “overweight” rating and a $43.00 price target for the company. KeyCorp initiated coverage on Hinge Health in a report on Monday. They set an “overweight” rating and a $45.00 price target on the stock. Canaccord Genuity Group assumed coverage on Hinge Health in a research note on Monday. They issued a “buy” rating and a $52.00 price objective for the company. Finally, Wall Street Zen raised Hinge Health to a “hold” rating in a research note on Monday, June 2nd. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $46.75.

Hinge Health Price Performance

Shares of NYSE:HNGE opened at $34.76 on Monday. Hinge Health has a one year low of $33.42 and a one year high of $43.80.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.